@article{6f72cd1b9b9d460ea496dad3da0acca5,
title = "Toward a vision for the development, study, and use of electronic health technology for and by people with psychiatric and/or substance use disorders: A strengths, weaknesses, opportunities, and threats analysis and illustration",
author = "Abraham Rudnick and David Roe",
note = "Funding Information: Dr. Rudnick has received research and development related financial support from Astra Zeneca, Eli Lilly, Janssen-Ortho, Mylan, and Novartis, manufacturers of psychotropic medications, in order to advance mental health care. He has also co-received research and development related financial support from Telus and Microsoft, communication and electronic industry companies, in order to advance mental healthcare. Dr. Roe identifies no involvement with private or related industry.",
year = "2012",
month = nov,
day = "1",
doi = "10.1080/15504263.2012.723314",
language = "American English",
volume = "8",
pages = "333--336",
journal = "Journal of Dual Diagnosis",
issn = "1550-4263",
publisher = "Routledge",
number = "4",
}